Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women between 35 and 50 years of age.
- Women who are attending or being followed up in a genetic counselling service related to cancer risk.
- Women who have been identified as having a higher risk of ovarian, fallopian tube, or peritoneal cancer based on specific gene mutations (BRCA1, BRCA2, RAD51C, RAD51D, or PALB2 — the list of mutations considered may be expanded during the study).
- Women who have given written agreement to take part in the trial.
- Women covered by the French Social Security health system.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Women who have previously had both ovaries removed and/or both fallopian tubes removed, for any reason.
- Women with a personal history of ovarian, fallopian tube, or peritoneal cancer.
- Women who have reached menopause — how this is determined depends on individual circumstances, including whether they have had chemotherapy or a hysterectomy, or have a progesterone-releasing intrauterine device (confirm with trial site).
- Women who would be unable to attend regular follow-up appointments for the trial due to geographical, social, or psychological reasons.
- Women who are under legal guardianship or curatorship.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carlos MARTINEZ GOMEZ, MD, Centre Oscar Lambret
Phone: 0320295918
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Advanced-Stage (Stage III or IV) Tubo-Ovarian or Primary Peritoneal Carcinoma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.